Reacción a "Using beta blockers does not benefit patients who have survived a heart attack with normal cardiac function, according to a new study"

These data, based on a sample of nearly 18,000 patients, confirm what many of us have suspected for some time and clarify doubts raised by seemingly disparate results from recent trials. It confirms that beta-blockers have no role in patients with myocardial infarction with preserved left ventricular ejection fraction. It is important to note that, with the expansion of revascularisation strategies, most patients with myocardial infarction have this preserved ejection fraction and therefore do not require this therapy, unless they have another clinical indication for beta-blockade. The message for patients is that, after a heart attack, if their heart is not weak, beta-blockers are not indicated.